Unver Suat, Ozmen Namik, Aparci Mustafa, Atasoyu E Murat, Evrenkaya T Rifki
GATA Haydarpasa Training Hospital, Department of Nephrology, Istanbul, Turkey.
Ren Fail. 2007;29(2):207-12. doi: 10.1080/08860220601098896.
Paroxysmal atrial fibrillation (AF) observed in patients undergoing chronic hemodialysis program with higher rates is an important morbidity and mortality cause that negatively influences the hemodynamics and leads to thromboembolic complications. It is known that P wave dispersion (PWD) facilitating the development of paroxysmal atrial fibrillation is increasing during intradialytic process. This study researched the influence of various amounts of ultrafiltration that applied in the various hemodialysis sessions in the same patient cohort on PWD.
25 patients in a chronic hemodialysis program undergoing four hours bicarbonate hemodialysis three times a week were included in the study. The patient cohort was divided into four groups regarding the amount of ultrafiltration (UF) performed during a four-hour standard hemodialysis session as following: UF up to 1 liter, UF of 1-2 liters, UF of 2-3 liters, and UF of 3-4 liters. Notes were kept until each patient had been included once into each group regarding the amount of ultrafiltration performed parallel to intradialytic weight gain in different hemodialysis session. A 12-lead ECG was taken from the patients immediately before the hemodialysis and within 20 minutes after completion of the session, and maximum P wave duration (Pmax), minimum P wave duration (Pmin) and PWD values (i.e., the difference between Pmax and Pmin) were measured. The inter-group data was assessed with a one-way ANOVA, and the within-group assessments were performed with paired samples test. Mann Whitney U test was used for the evaluations performed according to the presence of diabetes.
The mean age of 25 patients (15 male and 10 female) was 62.7 +/- 20.2 (range: 21-89). PWD after UF was decreased significantly in group 1 (56.12 +/- 15.26 vs. 46.60 +/- 18.45 ms, p = 0.018) and were increased in groups with UF more than 1 liter: group 2 (39.68 +/- 21.26 vs. 47.12 +/- 21.20 ms, p = 0.020), group 3 (41.60 +/- 23.99 vs. 65.92 +/- 31.04 ms, p = 0.001), and group 4 (17.52 +/- 14.67 vs. 26.80 +/- 15.52 ms, p = 0.007). Furthermore, while PWD before UF was significantly higher in a diabetic group compared to a nondiabetic group (68.85 +/- 10.44 vs. 51.16 +/- 14.06 ms, p = 0.007), it was seen that PWD difference had disappeared after UF application (57.14 +/- 17.99 vs. 42.50 +/- 17.40 ms, p = 0.065).
UF application of more than 1 liter during hemodialysis session increases the PWD value significantly. Hypervolemia exceeding 1 liter between two dialysis sessions should be avoided in all patient groups, especially in diabetics, and an effective UF planning should be arranged because of a decrease in PWD values with UF observed in diabetics.
在接受慢性血液透析治疗的患者中,阵发性心房颤动(AF)发生率较高,是一种重要的发病和死亡原因,会对血流动力学产生负面影响并导致血栓栓塞并发症。已知在透析过程中,促进阵发性心房颤动发生的P波离散度(PWD)会增加。本研究探讨了在同一患者队列的不同血液透析疗程中应用不同超滤量对PWD的影响。
本研究纳入了25例接受慢性血液透析治疗的患者,他们每周进行3次4小时的碳酸氢盐血液透析。根据4小时标准血液透析疗程中的超滤量(UF),将患者队列分为四组:超滤量达1升、1 - 2升、2 - 3升和3 - 4升。记录每位患者在不同血液透析疗程中与透析期间体重增加平行的超滤量,直至每位患者都被纳入每组一次。在血液透析前及透析结束后20分钟内,对患者进行12导联心电图检查,测量最大P波时限(Pmax)、最小P波时限(Pmin)和PWD值(即Pmax与Pmin之差)。组间数据采用单因素方差分析进行评估,组内评估采用配对样本检验。根据糖尿病的存在情况,采用Mann Whitney U检验进行评估。
25例患者(15例男性和10例女性)的平均年龄为62.7±20.2(范围:21 - 89岁)。第1组超滤后PWD显著降低(56.12±15.26对46.60±18.45毫秒,p = 0.018),超滤量超过1升的组PWD升高:第2组(39.68±21.26对47.12±21.20毫秒,p = 0.020),第3组(41.60±23.99对65.92±31.04毫秒,p = 0.001),第4组(17.52±14.67对26.80±15.52毫秒,p = 0.007)。此外,虽然超滤前糖尿病组的PWD显著高于非糖尿病组(68.85±10.44对51.16±14.06毫秒,p = 0.007),但超滤后PWD差异消失(57.14±17.99对42.50±17.40毫秒,p = 0.065)。
血液透析疗程中超滤量超过1升会显著增加PWD值。所有患者组,尤其是糖尿病患者,应避免两次透析期间超过1升的血容量过多,并且鉴于观察到糖尿病患者超滤后PWD值降低,应安排有效的超滤计划。